How much does having a neurologic disease affect QoL in non-CNS cancer patients?

被引：0
|
作者：
Cacho Diaz, Bernardo [1 ]
机构：
[1] Inst Nacl Cancerol Med Sur, Neuro Oncol, Mexico City, Mexico
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203970
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P7-13.002
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Are neurologic symptoms associated with worse QoL in non-CNS cancer patients?
    Cacho-Diaz, Bernardo
    Gonzalez-Gonzalez, Ethan
    Bonilla-Navarrete, Andres Mauricio
    Texcocano-Becerra, Julia
    Onate-Ocana, Luis F.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2023, 111 : 39 - 45
  • [2] HEADACHE IN PATIENTS WITH NON-CNS CANCER
    Cacho-Diaz, Bernardo
    Arrieta, Oscar
    NEURO-ONCOLOGY, 2022, 24 : 191 - 191
  • [3] HOW DOES HAVING A CHILD WITH CANCER AFFECT PARENTS' PSYCHOLOGY?
    Koc, Begum
    Tekkesin, Funda
    Balik, Zehra
    Kanat, Aysenur
    Yildirim, Ülku Miray
    Aydogdu, Selime
    Kilic, Suar
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S523 - S524
  • [4] HOW MUCH DOES LIVER-DISEASE AFFECT THE PHARMACOKINETICS OF ADRIAMYCIN
    KAYE, SB
    CUMMINGS, J
    KERR, DJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (08): : 893 - 895
  • [5] Living With Uveitis-How Much Does It Affect Our Patients?
    Tan, P. B.
    Chua, K.
    Teoh, S. C. B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [6] How much do patients with skin conditions itch, and how does it affect their lives?
    Campos-Rodenas, R.
    Boira, S.
    Marron, S. E.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) : 596 - 596
  • [7] How does gender-affirming hormone therapy affect QOL in transgender patients?
    Wilhelm, Sarah
    Kelsberg, Gary
    Safranek, Sarah
    JOURNAL OF FAMILY PRACTICE, 2022, 71 (10): : 442 - 444
  • [8] MAINTENANCE PEMETREXED OUTPATIENT THERAPY DOES NOT AFFECT QOL IN PATIENTS WITH NONSQUAMOUS NON-SMALL LUNG CANCER
    Ishiura, Y.
    Ikeda, H.
    Shiba, Y.
    Tearasaki, Y.
    Fukushima, W.
    Tanikawa, F.
    Hayase, H.
    Obata, C.
    Hirokami, N.
    Kasahara, K.
    ANNALS OF ONCOLOGY, 2013, 24
  • [9] Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status
    Drilon, A.
    Shen, L.
    van Tilburg, C. M.
    Tan, D. S. W.
    Kummar, S.
    Lin, J. J.
    Doz, F.
    McDermott, R.
    Albert, C. M.
    Berlin, J.
    Bielack, S.
    Lassen, U. N.
    Tahara, M.
    Norenberg, R.
    Fellous, M.
    Nogai, H.
    Xu, R.
    Laetsch, T. W.
    Hong, D. S.
    ANNALS OF ONCOLOGY, 2021, 32 : S599 - S599
  • [10] Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review
    Deprez, Sabine
    Billiet, Thibo
    Sunaert, Stefan
    Leemans, Alexander
    BRAIN IMAGING AND BEHAVIOR, 2013, 7 (04) : 409 - 435
12345